查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424998

胰臟癌治疗和诊断市场，按治疗类型、诊断、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Pancreatic Cancer Therapeutics & Diagnostics Market, By Treatment Type, Diagnostic, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年胰臟癌治疗和诊断市场规模为 24.706 亿美元，2023 年至 2030 年复合CAGR为 5.5%。

胰臟癌治疗与诊断市场-市场动态

胰臟癌发病率的上升、分子生物学、药物开发和诊断技术的进步预计将推动市场需求

市场成长是由胰臟癌发病率上升、分子生物学、药物开发和诊断技术的进步等因素所推动的。由于研发措施的增加、有利的报销方案以及创新产品的推出，市场可望大幅扩张。值得注意的是，2019 年1 月，Van Andel 研究所的科学家推出了一种新型血液检测（CA19-9 检测），与现有检测相结合，可以检测出近70% 的胰腺癌，假阳性率低于5%。此外，Myriad Genetics Inc. 于 2021 年 1 月宣布，其用于胰腺癌筛检的 BRACAnalysis 诊断系统将获得日本厚生劳动省的补偿，这可能会扩大日本基因检测的患者群体。积极塑造市场。 2020年10月，Oncolytics Biotech Inc.揭露了与罗氏和AIO合作进行的一项1/2期试验，评估pelareorep和atezolizumab治疗转移性胰臟癌的疗效。预计这些发展将对整个预测期内的市场成长产生有利影响。

胰臟癌治疗和诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球胰腺癌治疗和诊断市场在预测期内（2023-2030 年）每年将以 5.5% 左右的CAGR增长

由于胰臟癌发病率上升、分子生物学、药物开发和诊断技术的进步，癌症治疗和诊断市场预计将以显着的速度成长

根据最终用户，预计医院将在 2022 年显示最大的市场份额

从治疗来看，2022年化疗细分市场为主导类型

按地区划分，北美是 2022 年的主要收入来源

胰臟癌治疗与诊断市场-細項分析：

全球胰臟癌治疗和诊断市场根据治疗类型、诊断、最终用户和地区进行细分。

市场依治疗分为三类： 化疗。手术、其他治疗。在预测期内，预计化疗领域将在所研究的市场中发挥重要作用。化疗是治疗胰臟癌的主要方法，其作用是阻止胰臟癌细胞的生长和分裂，从而有效地杀死它们。这些化疗药物系统性地发挥作用，透过血流靶向并损害全身的癌细胞。

根据最终用户，市场分为四类：医院、诊所、实验室、其他。 2022年，就收入份额而言，胰臟癌诊断市场主要由医院部门主导。这种突出地位可归因于多种因素，包括对个性化药物的认识提高、可及的医疗服务的增强、患者到医院就诊的增加以及对战略倡议的日益重视，所有这些都促进了医院部门的增长。

胰臟癌治疗与诊断市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内主导市场。目标疾病发病率的上升以及营利性和非营利性组织尝试支持早期疾病识别的增加正在推动北美地区的扩张。胰臟癌行动网络是支持研究工作并提高人们对该疾病认识的一个着名团体。

胰臟癌治疗与诊断市场-竞争格局：

在胰臟癌治疗和诊断市场，各公司正在积极寻求策略，以利用对胰臟癌治疗和诊断不断增长的需求。在胰臟癌治疗领域，製药和生物技术公司参与各种活动，包括新产品发布、伙伴关係、协作和研究计划。

最近的发展：

2023年1月，梅奥诊所发布了透过临床研究对放射性示踪剂68Ga-纤维母细胞活化蛋白抑制剂（FAPI）-46在胰臟癌成像中的评估。

目录

第 1 章：胰臟癌治疗与诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按治疗类型分類的胰臟癌治疗和诊断市场片段
    • 胰臟癌治疗与诊断市场摘要（按 Diagnostics）
    • 最终用户的胰臟癌治疗和诊断市场片段
    • 按国家/地区分類的胰臟癌治疗和诊断市场片段
    • 按地区分類的胰臟癌治疗和诊断市场片段
  • 竞争洞察

第 3 章：胰臟癌治疗与诊断主要市场趋势

  • 胰臟癌治疗与诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 胰臟癌治疗与诊断市场限制
    • 市场限制影响分析
  • 胰臟癌治疗与诊断市场机会
  • 胰臟癌治疗与诊断市场未来趋势

第 4 章：胰臟癌治疗与诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：胰臟癌治疗与诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：胰臟癌治疗与诊断市场格局

  • 2022 年胰臟癌治疗与诊断市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：胰臟癌治疗与诊断市场 - 按治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 标靶治疗
    • 化疗
    • 手术
    • 其他治疗

第 8 章：胰臟癌治疗与诊断市场 - 按诊断

  • 概述
    • 细分市场占有率分析（按诊断）
    • 影像学
    • 活检
    • 超音波内视镜
    • 其他诊断

第 9 章：胰臟癌治疗和诊断市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 实验室
    • 其他的

第 10 章：胰臟癌治疗与诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美胰臟癌治疗和诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模和预测（根据 Diagnostics）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲胰臟癌治疗和诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模和预测（根据 Diagnostics）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区胰臟癌治疗和诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太市场规模和预测（根据 Diagnostics）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲胰臟癌治疗和诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模和预测（根据 Diagnostics）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲胰臟癌治疗和诊断主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按治疗类型）
    • 中东和非洲市场规模及预测（根据 Diagnostics）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 胰臟癌治疗与诊断产业

  • 竞争仪表板
  • 公司简介
    • Myriad Genetics Inc.
    • Pfizer Inc.
    • Novartis AG
    • Bristol-Myers Squibb Company
    • AstraZeneca PLC
    • Amgen Inc.
    • Viatris Inc.
    • Boston Scientific Corporation
    • FUJIFILM Holdings Corporation
    • Canon Inc. (canon Medical Systems Corporation)

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2198

REPORT HIGHLIGHT

Pancreatic Cancer Therapeutics & Diagnostics Market size was valued at USD 2,470.6 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.

Pancreatic cancer therapeutics and diagnostics encompass medical procedures for both the diagnosis and subsequent treatment of pancreatic cancer. Globally, pancreatic cancer stands as a significant contributor to cancer-related fatalities, with the disease burden escalating rapidly. According to the American Cancer Society, the 5-year relative survival rates are approximately 44% for localized cases, 15% for regional cases, and 3% for distant cases. In response, healthcare professionals and authorities are underscoring the need to develop and commercialize precise screening methods to monitor prevalence levels.

Pancreatic Cancer Therapeutics & Diagnostics Market- Market Dynamics

Rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology is expected to propel the market demand

The market growth is driven by factors such as the rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology. The market is poised for significant expansion due to increased research and development initiatives, favorable reimbursement scenarios, and the introduction of innovative products. Notably, in January 2019, scientists at the Van Andel Research Institute introduced a novel blood test (CA19-9 test) that, when combined with an existing test, can detect nearly 70% of pancreatic cancers with a false-positive rate of less than 5%. Additionally, Myriad Genetics Inc. announced in January 2021 that its BRACAnalysis Diagnostic System, used for pancreatic cancer screening, would receive reimbursement from Japan's Ministry of Health, Labour, and Welfare, potentially expanding the patient pool for genetic testing in Japan.Collaborations are also shaping the market positively. In October 2020, Oncolytics Biotech Inc. disclosed a collaboration with Roche and AIO for a phase 1/2 trial evaluating the efficacy of pelareorep and atezolizumab in treating metastatic pancreatic cancer. These developments are anticipated to have a favorable impact on market growth throughout the forecast period.

Pancreatic Cancer Therapeutics & Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global Pancreatic Cancer Therapeutics & Diagnostics Market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)

The Cancer Therapeutics & Diagnostics Market is projected to grow at a significant rate due to rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology

Based on end user, hospital was predicted to show maximum market share in the year 2022

Based on Treatment, chemotherapy segment was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Pancreatic Cancer Therapeutics & Diagnostics Market- Segmentation Analysis:

The Global Pancreatic Cancer Therapeutics & Diagnostics Market is segmented on the basis of Treatment Type, Diagnostic, By End User, and Region.

The market is divided into three categories based on Treatment: Chemotherapy. Surgery, Other Treatments. Over the forecast period, it is anticipated that the chemotherapy segment will play a significant role in the studied market. Chemotherapy stands as a primary method of treating pancreatic cancer, functioning by impeding the growth and division of pancreatic cancer cells, effectively killing them. These chemotherapy drugs operate systemically, traveling through the bloodstream to target and damage cancer cells throughout the entire body.

The market is divided into four categories based on End User: Hospitals, Clinics, Laboratories, Others. In 2022, the pancreatic cancer diagnostics market was predominantly led by the hospitals segment in terms of revenue share. This prominence can be attributed to several factors, including heightened awareness of personalized medicines, enhancements in accessible healthcare services, an uptick in patient visits to hospitals, and an increasing emphasis on strategic initiatives, all of which are bolstering the growth of the hospital segment.

Pancreatic Cancer Therapeutics & Diagnostics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The target illness's rising incidence and the rise in for-profit and nonprofit organizations' attempts to support early disease identification are driving the expansion of the North American area. One well-known group that supports research efforts and raises awareness of the disease is the Pancreatic Cancer Action Network.

Pancreatic Cancer Therapeutics & Diagnostics Market- Competitive Landscape:

In the pancreatic cancer therapeutic & diagnostic market, companies are actively pursuing strategies to capitalize on the increasing demand for Pancreatic Cancer Therapeutics & Diagnostics. In the field of pancreatic cancer therapeutics, pharmaceutical and biotechnology companies are involved in various activities, including new product launches, partnerships, collaborations, and research initiatives.

Recent Developments:

In January 2023, the evaluation of the radiotracer, 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46, in pancreatic cancer imaging through a clinical study was released by Mayo Clinic.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET KEY PLAYERS

  • Myriad Genetics Inc.
  • Pfizer Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC
  • Amgen Inc.
  • Viatris Inc.
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Canon Inc. (canon Medical Systems Corporation)

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY TREATMENT TYPE

  • Targeted Therapies
  • Chemotherapy
  • Surgery
  • Other Treatments

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTIC

  • Imaging
  • Biopsy
  • Endoscopic Ultrasound
  • Other Diagnostics

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY END USER

  • Hospitals
  • Clinics
  • Laboratories
  • Others

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pancreatic Cancer Therapeutics & Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Treatment Type
    • 2.1.2. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Diagnostics
    • 2.1.3. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by End Users
    • 2.1.4. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Country
    • 2.1.5. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Pancreatic Cancer Therapeutics & Diagnostics Key Market Trends

  • 3.1. Pancreatic Cancer Therapeutics & Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pancreatic Cancer Therapeutics & Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pancreatic Cancer Therapeutics & Diagnostics Market Opportunities
  • 3.4. Pancreatic Cancer Therapeutics & Diagnostics Market Future Trends

4. Pancreatic Cancer Therapeutics & Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pancreatic Cancer Therapeutics & Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pancreatic Cancer Therapeutics & Diagnostics Market Landscape

  • 6.1. Pancreatic Cancer Therapeutics & Diagnostics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pancreatic Cancer Therapeutics & Diagnostics Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 7.1.2. Targeted Therapies
    • 7.1.3. Chemotherapy
    • 7.1.4. Surgery
    • 7.1.5. Other Treatments

8. Pancreatic Cancer Therapeutics & Diagnostics Market - By Diagnostics

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnostics, 2022 & 2030 (%)
    • 8.1.2. Imaging
    • 8.1.3. Biopsy
    • 8.1.4. Endoscopic Ultrasound
    • 8.1.5. Other Diagnostics

9. Pancreatic Cancer Therapeutics & Diagnostics Market - By End Users

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Users, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Laboratories
    • 9.1.5. Others

10. Pancreatic Cancer Therapeutics & Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pancreatic Cancer Therapeutics & Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Myriad Genetics Inc.
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Novartis AG
    • 11.2.4. Bristol-Myers Squibb Company
    • 11.2.5. AstraZeneca PLC
    • 11.2.6. Amgen Inc.
    • 11.2.7. Viatris Inc.
    • 11.2.8. Boston Scientific Corporation
    • 11.2.9. FUJIFILM Holdings Corporation
    • 11.2.10. Canon Inc. (canon Medical Systems Corporation)

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Diagnostics Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diagnostics
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics 2018-2030 (USD Million)
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: End Users Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End Users
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users 2018-2030 (USD Million)
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)